Intestinal fatty acid-binding protein in celiac disease: Finding its place in diagnosis and monitoring
Author:
Open Access
- 9 July 2025
- journal article
- editorial
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (1) , 3-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Role of intestinal fatty acid binding protein in the non-invasive diagnosis of celiac disease in childrenIndian Journal of Gastroenterology, 2025
- ESPGHAN Position Paper on Management and Follow‐up of Children and Adolescents With Celiac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2022
- Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference CentreNutrients, 2022
- Intestinal Fatty Acid Binding Protein Levels in Pediatric Celiac Patients in Transition From Active Disease to Clinical and Serological RemissionJPGN Reports, 2021
- The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal DiseasesDigestive Diseases and Sciences, 2019
- Non‐immunological biomarkers for assessment of villous abnormalities in patients with celiac diseaseJournal of Gastroenterology and Hepatology, 2019
- Non-Invasive Biomarkers for Celiac DiseaseJournal of Clinical Medicine, 2019
- Serum intestinal fatty acid–binding protein in the noninvasive diagnosis of celiac diseaseAPMIS, 2018
- Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten ChallengeAmerican Journal of Gastroenterology, 2016
- Serum I‐FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodiesAlimentary Pharmacology & Therapeutics, 2013